Home » Author Archive

$0.24 Earnings Per Share Expected for Finisar Co. (NASDAQ:FNSR) This Quarter

$0.24 Earnings Per Share Expected for Finisar Co. (NASDAQ:FNSR) This Quarter

Equities analysts expect that Finisar Co. (NASDAQ:FNSR) will post earnings of $0.24 per share for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Finisar’s earnings, with... 
Blue Bird Corp (NASDAQ:BLBD) Given Consensus Rating of “Strong Buy” by Analysts

Blue Bird Corp (NASDAQ:BLBD) Given Consensus Rating of “Strong Buy” by Analysts

Shares of Blue Bird Corp (NASDAQ:BLBD) have received an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a... 
Macerich Co (NYSE:MAC) Receives Average Rating of “Hold” from Analysts

Macerich Co (NYSE:MAC) Receives Average Rating of “Hold” from Analysts

Shares of Macerich Co (NYSE:MAC) have earned an average recommendation of “Hold” from the seventeen research firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts... 
Zacks: Brokerages Expect HMS Holdings Corp (NASDAQ:HMSY) Will Announce Earnings of $0.26 Per Share

Zacks: Brokerages Expect HMS Holdings Corp (NASDAQ:HMSY) Will Announce Earnings of $0.26 Per Share

Brokerages expect HMS Holdings Corp (NASDAQ:HMSY) to post earnings per share (EPS) of $0.26 for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for HMS’s earnings, with the highest EPS... 
-$0.37 Earnings Per Share Expected for Miragen Therapeutics Inc (NASDAQ:MGEN) This Quarter

-$0.37 Earnings Per Share Expected for Miragen Therapeutics Inc (NASDAQ:MGEN) This Quarter

Analysts predict that Miragen Therapeutics Inc (NASDAQ:MGEN) will report earnings of ($0.37) per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Miragen Therapeutics’... 
JetBlue Airways Co. (NASDAQ:JBLU) Expected to Announce Earnings of $0.57 Per Share

JetBlue Airways Co. (NASDAQ:JBLU) Expected to Announce Earnings of $0.57 Per Share

Equities analysts expect that JetBlue Airways Co. (NASDAQ:JBLU) will announce earnings per share of $0.57 for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for JetBlue Airways’... 
$39.91 Million in Sales Expected for Monmouth R.E. Inv. Corp. (NYSE:MNR) This Quarter

$39.91 Million in Sales Expected for Monmouth R.E. Inv. Corp. (NYSE:MNR) This Quarter

Wall Street brokerages expect Monmouth R.E. Inv. Corp. (NYSE:MNR) to post sales of $39.91 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Monmouth R.E. Inv.’s earnings,... 
Zacks: Brokerages Expect Plymouth Ind Re (NASDAQ:PLYM) to Announce $0.48 Earnings Per Share

Zacks: Brokerages Expect Plymouth Ind Re (NASDAQ:PLYM) to Announce $0.48 Earnings Per Share

Wall Street analysts forecast that Plymouth Ind Re (NASDAQ:PLYM) will announce earnings of $0.48 per share for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Plymouth Ind... 
Zacks: Analysts Expect Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Will Post Earnings of -$0.10 Per Share

Zacks: Analysts Expect Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Will Post Earnings of -$0.10 Per Share

Brokerages expect Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) to announce ($0.10) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Sunesis... 
Merus NV (NASDAQ:MRUS) Expected to Post Earnings of -$0.54 Per Share

Merus NV (NASDAQ:MRUS) Expected to Post Earnings of -$0.54 Per Share

Wall Street analysts expect Merus NV (NASDAQ:MRUS) to report earnings of ($0.54) per share for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Merus’ earnings. The lowest EPS estimate... 
Peoples Utah Bancorp (NASDAQ:PUB) Raised to “Hold” at Zacks Investment Research

Peoples Utah Bancorp (NASDAQ:PUB) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Peoples Utah Bancorp (NASDAQ:PUB) from a sell rating to a hold rating in a research note issued to investors on Friday morning, Zacks.com reports. According to Zacks, “People’s... 
CNB Financial (NASDAQ:CCNE) Announces  Earnings Results

CNB Financial (NASDAQ:CCNE) Announces Earnings Results

CNB Financial (NASDAQ:CCNE) released its quarterly earnings data on Friday. The bank reported $0.64 EPS for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.03, MarketWatch Earnings reports. The company... 
CVS Health Corp (CVS) To Go Ex-Dividend on July 24th

CVS Health Corp (CVS) To Go Ex-Dividend on July 24th

CVS Health Corp (NYSE:CVS) declared a quarterly dividend on Wednesday, July 10th, RTT News reports. Shareholders of record on Thursday, July 25th will be given a dividend of 0.50 per share by the pharmacy operator on Friday,... 
Northwest Natural (NYSE:NWN) Rating Lowered to Hold at Zacks Investment Research

Northwest Natural (NYSE:NWN) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research cut shares of Northwest Natural (NYSE:NWN) from a buy rating to a hold rating in a report issued on Friday, Zacks.com reports. According to Zacks, “Northwest Natural Holding Company builds and... 
Otonomy (NASDAQ:OTIC) Stock Rating Lowered by Zacks Investment Research

Otonomy (NASDAQ:OTIC) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research cut shares of Otonomy (NASDAQ:OTIC) from a buy rating to a hold rating in a report released on Thursday morning, Zacks.com reports. According to Zacks, “Otonomy, Inc. engages in developing and... 
KeyCorp Begins Coverage on Redfin (NASDAQ:RDFN)

KeyCorp Begins Coverage on Redfin (NASDAQ:RDFN)

KeyCorp initiated coverage on shares of Redfin (NASDAQ:RDFN) in a research report sent to investors on Friday, BenzingaRatingsTable reports. The brokerage issued a sector weight rating and a $18.00 price target on the stock.... 
Barclays Boosts Visa (NYSE:V) Price Target to $195.00

Barclays Boosts Visa (NYSE:V) Price Target to $195.00

Visa (NYSE:V) had its price objective hoisted by Barclays from $181.00 to $195.00 in a report issued on Friday morning, BenzingaRatingsTable reports. They currently have an overweight rating on the credit-card processor’s... 
Gartner (NYSE:IT) Price Target Raised to $156.00

Gartner (NYSE:IT) Price Target Raised to $156.00

Gartner (NYSE:IT) had its target price upped by Morgan Stanley from $148.00 to $156.00 in a report issued on Friday morning, BenzingaRatingsTable reports. They currently have an equal weight rating on the information technology... 
Clearway Energy (NYSE:CWEN) Upgraded to Buy by Zacks Investment Research

Clearway Energy (NYSE:CWEN) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Clearway Energy (NYSE:CWEN) from a hold rating to a buy rating in a research note issued to investors on Friday, Zacks.com reports. Zacks Investment Research currently has $19.00... 
Longbow Research Lowers Allegheny Technologies (NYSE:ATI) to Neutral

Longbow Research Lowers Allegheny Technologies (NYSE:ATI) to Neutral

Longbow Research downgraded shares of Allegheny Technologies (NYSE:ATI) from a buy rating to a neutral rating in a report published on Thursday, Benzinga reports. The firm currently has $24.45 price target on the basic materials... 
WNS (NYSE:WNS) PT Raised to $70.00 at Cowen

WNS (NYSE:WNS) PT Raised to $70.00 at Cowen

WNS (NYSE:WNS) had its target price upped by Cowen from $62.00 to $70.00 in a research report sent to investors on Friday, The Fly reports. The brokerage currently has an outperform rating on the business services provider’s... 
Marina Biotech (OTCMKTS:MRNA) Stock Rating Lowered by Zacks Investment Research

Marina Biotech (OTCMKTS:MRNA) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research lowered shares of Marina Biotech (OTCMKTS:MRNA) from a hold rating to a sell rating in a research report released on Thursday morning, Zacks.com reports. According to Zacks, “Moderna Inc. is... 
Netflix (NASDAQ:NFLX) PT Raised to $188.00 at Wedbush

Netflix (NASDAQ:NFLX) PT Raised to $188.00 at Wedbush

Netflix (NASDAQ:NFLX) had its price objective increased by Wedbush from $183.00 to $188.00 in a report released on Thursday morning, The Fly reports. They currently have an underperform rating on the Internet television network’s... 
Insider Buying: First United Corp (NASDAQ:FUNC) CEO Purchases $100,000.00 in Stock

Insider Buying: First United Corp (NASDAQ:FUNC) CEO Purchases $100,000.00 in Stock

First United Corp (NASDAQ:FUNC) CEO Carissa Lynn Rodeheaver acquired 5,000 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was bought at an average cost of $20.00 per share,... 
istar Inc (NYSE:STAR) Major Shareholder Purchases $158,850.00 in Stock

istar Inc (NYSE:STAR) Major Shareholder Purchases $158,850.00 in Stock

istar Inc (NYSE:STAR) major shareholder Istar Inc. acquired 5,000 shares of istar stock in a transaction dated Wednesday, July 17th. The shares were acquired at an average price of $31.77 per share, with a total value of $158,850.00.... 
Catasys (NASDAQ:CATS) Raised to Hold at BidaskClub

Catasys (NASDAQ:CATS) Raised to Hold at BidaskClub

BidaskClub upgraded shares of Catasys (NASDAQ:CATS) from a sell rating to a hold rating in a research note published on Friday, BidAskClub reports. CATS has been the subject of a number of other research reports. Dougherty &... 
Comparing Eldorado Gold (NYSE:EGO) and Coeur Mining (NYSE:CDE)

Comparing Eldorado Gold (NYSE:EGO) and Coeur Mining (NYSE:CDE)

Eldorado Gold (NYSE:EGO) and Coeur Mining (NYSE:CDE) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk,... 
Reviewing Viveve Medical (NASDAQ:VIVE) & Vaso (NASDAQ:VASO)

Reviewing Viveve Medical (NASDAQ:VIVE) & Vaso (NASDAQ:VASO)

Viveve Medical (NASDAQ:VIVE) and Vaso (OTCMKTS:VASO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends,... 
Genesco (NYSE:GCO) Downgraded by ValuEngine

Genesco (NYSE:GCO) Downgraded by ValuEngine

ValuEngine downgraded shares of Genesco (NYSE:GCO) from a hold rating to a sell rating in a research note issued to investors on Friday, ValuEngine reports. Other equities research analysts have also recently issued research... 
Insider Selling: Teladoc Health Inc (NYSE:TDOC) President Sells $2,058,251.76 in Stock

Insider Selling: Teladoc Health Inc (NYSE:TDOC) President Sells $2,058,251.76 in Stock

Teladoc Health Inc (NYSE:TDOC) President Peter A. Mcclennen sold 29,412 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $69.98, for a total value of $2,058,251.76....